Detailed Notes on Histamine, Antihistamines, and Immunopharmacology
Histamine and Its Role
Histamine: A chemical messenger generated in mast cells, mediating various cellular responses.
Functions include allergic/inflammatory reactions, gastric acid secretion, neurotransmission.
No direct clinical applications; however, antihistamines are used to inhibit histamine's effects.
Synthesis, Release, and Mechanism of Action of Histamine
Locations: Found throughout the body; significant in:
Mast cells and basophils: High concentrations.
Also in lungs, skin, blood vessels, and GI tract.
Synthesis: Derived from the amino acid histidine via decarboxylation by histidine decarboxylase.
Release Triggers: Various stimuli including trauma, toxins, and allergens can stimulate histamine release.
Histamine Receptor Types and Their Effects
H1 Receptors:
Mediate allergic reactions, bronchial constriction, increased mucus, itching, and pain.
Important for conditions like allergy, asthma, and anaphylaxis.
H2 Receptors:
Stimulation leads to increased gastric acid secretion.
H3 and H4 Receptors:
Less understood; involved in neurotransmitter release and immune responses.
Antihistamines Overview
Definition: Primarily H1-receptor blockers used to treat allergic conditions.
Generations:
First Generation: Older drugs like diphenhydramine; cause sedation.
Second Generation: Newer drugs such as loratadine; less sedating, specific for peripheral H1 receptors.
Actions and Therapeutic Uses of H1 Antihistamines
Actions: Block the effects of histamine; effective in preventing allergic symptoms rather than reversing them.
Therapeutic Uses:
Allergic conditions: Allergy rhinitis, urticaria.
Motion sickness: Drugs like dimenhydrinate and meclizine.
Insomnia: First-generation antihistamines can be sedative.
Pharmacokinetics and Adverse Effects
Pharmacokinetics: Well absorbed, peak plasma levels at 1-2 hours.
Half-life varies; first-generation longer due to extensive metabolism.
Adverse Effects:
Common: Sedation, dry mouth, urinary retention.
First-generation antihistamines have more side effects due to interactions with other receptors (cholinergic, adrenergic).
Immunopharmacology Summary
Induction Immunosuppressants: Used post-transplant to prevent rejection, include monoclonal antibodies:
Examples: Alemtuzumab (targets CD52), basiliximab (blocks IL-2 receptor).
Maintenance Immunosuppressants: Prevent allograft rejection with less risk of adverse effects; include azathioprine, mycophenolate, calcineurin inhibitors (cyclosporine, tacrolimus).
Mechanisms: Each class works by different pathways to suppress immune responses.
Alerts and Monitoring for Immunosuppressants
Monitor for infections, potential malignancies, and drug interactions.
Adjust dosage based on therapeutic drug monitoring and half-lives.
Histamine: A chemical messenger generated in mast cells, mediating various cellular responses.
Functions include allergic/inflammatory reactions, gastric acid secretion, neurotransmission.
No direct clinical applications; however, antihistamines are used to inhibit histamine's effects.
Synthesis, Release, and Mechanism of Action of Histamine
Locations: Found throughout the body; significant in:
Mast cells and basophils: High concentrations.
Also in lungs, skin, blood vessels, and GI tract.
Synthesis: Derived from the amino acid histidine via decarboxylation by histidine decarboxylase.
Release Triggers: Various stimuli including trauma, toxins, and allergens can stimulate histamine release.
Histamine Receptor Types and Their Effects
H1 Receptors:
Mediate allergic reactions, bronchial constriction, increased mucus, itching, and pain.
Important for conditions like allergy, asthma, and anaphylaxis.H2 Receptors:
Stimulation leads to increased gastric acid secretion.H3 and H4 Receptors:
Less understood; involved in neurotransmitter release and immune responses.
Antihistamines Overview
Definition: Primarily H1-receptor blockers used to treat allergic conditions.
Generations:
First Generation: Older drugs like diphenhydramine; cause sedation.
Second Generation: Newer drugs such as loratadine; less sedating, specific for peripheral H1 receptors.
Actions and Therapeutic Uses of H1 Antihistamines
Actions: Block the effects of histamine; effective in preventing allergic symptoms rather than reversing them.
Therapeutic Uses:
Allergic conditions: Allergy rhinitis, urticaria.
Motion sickness: Drugs like dimenhydrinate and meclizine.
Insomnia: First-generation antihistamines can be sedative.
Pharmacokinetics and Adverse Effects
Pharmacokinetics: Well absorbed, peak plasma levels at 1-2 hours.
Half-life varies; first-generation longer due to extensive metabolism.
Adverse Effects:
Common: Sedation, dry mouth, urinary retention.
First-generation antihistamines have more side effects due to interactions with other receptors (cholinergic, adrenergic).
Immunopharmacology Summary
Induction Immunosuppressants: Used post-transplant to prevent rejection, include monoclonal antibodies:
Examples: Alemtuzumab (targets CD52), basiliximab (blocks IL-2 receptor).
Maintenance Immunosuppressants: Prevent allograft rejection with less risk of adverse effects; include azathioprine, mycophenolate, calcineurin inhibitors (cyclosporine, tacrolimus).
Mechanisms: Each class works by different pathways to suppress immune responses.
Alerts and Monitoring for Immunosuppressants
Monitor for infections, potential malignancies, and drug interactions.
Adjust dosage based on therapeutic drug monitoring
Histamine: A chemical messenger generated in mast cells, mediating various cellular responses.
Functions include allergic/inflammatory reactions, gastric acid secretion, neurotransmission.
No direct clinical applications; however, antihistamines are used to inhibit histamine's effects.
Synthesis, Release, and Mechanism of Action of Histamine
Locations: Found throughout the body; significant in:
Mast cells and basophils: High concentrations.
Also in lungs, skin, blood vessels, and GI tract.
Synthesis: Derived from the amino acid histidine via decarboxylation by histidine decarboxylase.
Release Triggers: Various stimuli including trauma, toxins, and allergens can stimulate histamine release.
Histamine Receptor Types and Their Effects
H1 Receptors:
Mediate allergic reactions, bronchial constriction, increased mucus, itching, and pain.
Important for conditions like allergy, asthma, and anaphylaxis.H2 Receptors:
Stimulation leads to increased gastric acid secretion.H3 and H4 Receptors:
Less understood; involved in neurotransmitter release and immune responses.
Antihistamines Overview
Definition: Primarily H1-receptor blockers used to treat allergic conditions.
Generations:
First Generation: Older drugs like diphenhydramine; cause sedation.
Second Generation: Newer drugs such as loratadine; less sedating, specific for peripheral H1 receptors.
Actions and Therapeutic Uses of H1 Antihistamines
Actions: Block the effects of histamine; effective in preventing allergic symptoms rather than reversing them.
Therapeutic Uses:
Allergic conditions: Allergy rhinitis, urticaria.
Motion sickness: Drugs like dimenhydrinate and meclizine.
Insomnia: First-generation antihistamines can be sedative.
Pharmacokinetics and Adverse Effects
Pharmacokinetics: Well absorbed, peak plasma levels at 1-2 hours.
Half-life varies; first-generation longer due to extensive metabolism.
Adverse Effects:
Common: Sedation, dry mouth, urinary retention.
First-generation antihistamines have more side effects due to interactions with other receptors (cholinergic, adrenergic).
Immunopharmacology Summary
Induction Immunosuppressants: Used post-transplant to prevent rejection, include monoclonal antibodies:
Examples: Alemtuzumab (targets CD52), basiliximab (blocks IL-2 receptor).
Maintenance Immunosuppressants: Prevent allograft rejection with less risk of adverse effects; include azathioprine, mycophenolate, calcineurin inhibitors (cyclosporine, tacrolimus).
Mechanisms: Each class works by different pathways to suppress immune responses.
Alerts and Monitoring for Immunosuppressants
Monitor for infections, potential malignancies, and drug interactions.
Adjust dosage based on therapeutic drug monitoring